Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study.

Carlson AL, Kanapka LG, Miller KM, Ahmann AJ, Chaytor NS, Fox S, Kiblinger L, Kruger D, Levy CJ, Peters AL, Rickels MR, Salam M, Shah VN, Young LA, Kudva YC, Pratley R; WISDM Study Group.

J Diabetes Sci Technol. 2019 Dec 21:1932296819894974. doi: 10.1177/1932296819894974. [Epub ahead of print]

PMID:
31867988
2.

Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults.

Kudva YC, Ahmann AJ, Bergenstal RM, Gavin JR 3rd, Kruger DF, Midyett LK, Miller E, Harris DR.

J Endocr Soc. 2018 Nov 14;2(12):1320-1337. doi: 10.1210/js.2018-00294. eCollection 2018 Dec 1. Review.

3.

Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines.

Peters AL, Ahmann AJ, Hirsch IB, Raymond JK.

J Endocr Soc. 2018 Oct 5;2(11):1214-1225. doi: 10.1210/js.2018-00262. eCollection 2018 Nov 1.

4.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, Weinstock RS, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1445-1460. doi: 10.1210/js.2017-00388. eCollection 2017 Dec 1.

5.

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.

Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR.

Diabetes Care. 2018 Feb;41(2):258-266. doi: 10.2337/dc17-0417. Epub 2017 Dec 15.

PMID:
29246950
6.

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.

Beck RW, Riddlesworth TD, Ruedy KJ, Kollman C, Ahmann AJ, Bergenstal RM, Bhargava A, Bode BW, Haller S, Kruger DF, McGill JB, Polonsky W, Price D, Toschi E; DIAMOND Study Group.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):700-708. doi: 10.1016/S2213-8587(17)30217-6. Epub 2017 Jul 12.

PMID:
28711468
7.

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.

Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peters AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW; REPLACE-BG Study Group.

Diabetes Care. 2017 Apr;40(4):538-545. doi: 10.2337/dc16-2482. Epub 2017 Feb 16.

8.

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections.

Bergenstal RM, Bailey TS, Rodbard D, Ziemen M, Guo H, Muehlen-Bartmer I, Ahmann AJ.

Diabetes Care. 2017 Apr;40(4):554-560. doi: 10.2337/dc16-0684. Epub 2017 Jan 23.

PMID:
28115474
9.

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.

Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, Winter WE, Wolpert H.

J Clin Endocrinol Metab. 2016 Nov;101(11):3922-3937. Epub 2016 Sep 2.

PMID:
27588440
10.

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270.

Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators.

Diabetes Care. 2016 Oct;39(10):e193-4. doi: 10.2337/dci16-0025. No abstract available.

11.

Reliability of Trained Dogs to Alert to Hypoglycemia in Patients With Type 1 Diabetes.

Los EA, Ramsey KL, Guttmann-Bauman I, Ahmann AJ.

J Diabetes Sci Technol. 2017 May;11(3):506-512. doi: 10.1177/1932296816666537. Epub 2016 Aug 28.

12.

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.

Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators.

Diabetes Care. 2016 Feb;39(2):264-70. doi: 10.2337/dc15-1498. Epub 2015 Dec 17.

13.

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes.

Weinstock RS, DuBose SN, Bergenstal RM, Chaytor NS, Peterson C, Olson BA, Munshi MN, Perrin AJ, Miller KM, Beck RW, Liljenquist DR, Aleppo G, Buse JB, Kruger D, Bhargava A, Goland RS, Edelen RC, Pratley RE, Peters AL, Rodriguez H, Ahmann AJ, Lock JP, Garg SK, Rickels MR, Hirsch IB; T1D Exchange Severe Hypoglycemia in Older Adults With Type 1 Diabetes Study Group.

Diabetes Care. 2016 Apr;39(4):603-10. doi: 10.2337/dc15-1426. Epub 2015 Dec 17.

PMID:
26681721
14.

Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study.

Weiss R, Garg SK, Bode BW, Bailey TS, Ahmann AJ, Schultz KA, Welsh JB, Shin JJ.

Diabetes Technol Ther. 2015 Aug;17(8):542-7. doi: 10.1089/dia.2014.0306. Epub 2015 Jun 2.

15.

Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S; T1D Exchange Clinic Network.

Diabetes Care. 2015 Apr;38(4):e61. doi: 10.2337/dc14-2782. No abstract available.

PMID:
25805875
16.

Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes.

Davis AK, DuBose SN, Haller MJ, Miller KM, DiMeglio LA, Bethin KE, Goland RS, Greenberg EM, Liljenquist DR, Ahmann AJ, Marcovina SM, Peters AL, Beck RW, Greenbaum CJ; T1D Exchange Clinic Network.

Diabetes Care. 2015 Mar;38(3):476-81. doi: 10.2337/dc14-1952. Epub 2014 Dec 17.

PMID:
25519448
17.

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.

Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S; T1D Exchange Clinic Network.

Diabetes Care. 2014 Oct;37(10):2702-9. doi: 10.2337/dc14-0303. Epub 2014 Jul 10.

18.

Can trained dogs detect a hypoglycemic scent in patients with type 1 diabetes?

Dehlinger K, Tarnowski K, House JL, Los E, Hanavan K, Bustamante B, Ahmann AJ, Ward WK.

Diabetes Care. 2013 Jul;36(7):e98-9. doi: 10.2337/dc12-2342. No abstract available.

19.

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group.

N Engl J Med. 2013 Jul 18;369(3):224-32. doi: 10.1056/NEJMoa1303576. Epub 2013 Jun 22.

20.

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile.

Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM.

J Diabetes Sci Technol. 2013 Mar 1;7(2):562-78.

21.

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).

Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM.

Diabetes Technol Ther. 2013 Mar;15(3):198-211. doi: 10.1089/dia.2013.0051. Epub 2013 Feb 28.

PMID:
23448694
22.

Treating to target: implementing an effective diabetes care paradigm for managed care.

Berger JE, Ahmann AJ, Balfour DC, Owens GS, Beltran R, Bush MA, Culpepper L, Owens GS, Ringel M, Welty FK.

Am J Manag Care. 2010 Mar;16 Suppl Treating:S4-35. Review. No abstract available.

23.

Designing and implementing insulin infusion protocols and order sets.

Ahmann AJ, Maynard G.

J Hosp Med. 2008 Sep;3(5 Suppl):42-54. doi: 10.1002/jhm.366.

PMID:
18951382
24.

Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus.

Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, Welles BR.

Clin Ther. 2008 Jun;30(6):1081-8. doi: 10.1016/j.clinthera.2008.05.021.

PMID:
18640464
25.

The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.

Hoerger TJ, Ahmann AJ.

J Manag Care Pharm. 2008 Feb;14(1 Suppl C):S2-14; quiz 15-6. Review.

26.
27.

Ultradian variation of blood glucose in intensive care unit patients receiving insulin infusions.

Smith SM, Oveson KE, Strauss W, Raven K, Lefevre MC, Ahmann AJ, Hagg DS.

Diabetes Care. 2007 Oct;30(10):2503-5. Epub 2007 Jul 20. No abstract available.

PMID:
17644616
28.

Guidelines and performance measures for diabetes.

Ahmann AJ.

Am J Manag Care. 2007 Apr;13 Suppl 2:S41-6. Review.

29.

Inpatient management of hospitalized patients with type 2 diabetes.

Ahmann AJ.

Curr Diab Rep. 2004 Oct;4(5):346-51. Review.

PMID:
15461899
30.

What to do when two oral agents fail to control type 2 diabetes--a matter of opinion or a matter of fact?

Ahmann AJ, Riddle MC.

Am J Med. 2004 Feb 15;116(4):276-8. No abstract available.

PMID:
14969657
31.

Current oral agents for type 2 diabetes. Many options, but which to choose when?

Ahmann AJ, Riddle MC.

Postgrad Med. 2002 May;111(5):32-4, 37-40, 43-6. Review.

PMID:
12040862
32.

Effects of epidermal growth factor on thyroglobulin and adenosine 3',5'-monophosphate production by cultured human thyrocytes.

Tseng YC, Burman KD, Schaudies RP, Ahmann AJ, D'Avis J, Geelhoed GW, Wartofsky L.

J Clin Endocrinol Metab. 1989 Oct;69(4):771-5.

PMID:
2550506
33.

[Molecular genetic detection of polyclonal immune response in autoimmune thyroiditis and inflammatory bowel diseases].

Kaulfersch W, Baker JR, Burman KD, Fiocchi C, Ahmann AJ, D'Avis JC, Waldmann TA.

Monatsschr Kinderheilkd. 1989 Sep;137(9):610-5. German.

PMID:
2554127
34.

Thyrotropin modulates receptors for atrial natriuretic peptide on intact human thyroid cells.

Tseng YC, Sellitti DF, Ahmann AJ, Burman KD, D'Avis JC, Wartofsky L.

Am J Med Sci. 1989 Jul;298(1):15-9.

PMID:
2546425
35.

Immunoglobulin and T cell antigen receptor gene arrangements indicate that the immune response in autoimmune thyroid disease is polyclonal.

Kaulfersch W, Baker JR Jr, Burman KD, Ahmann AJ, D'Avis JC, Waldmann TA.

J Clin Endocrinol Metab. 1988 May;66(5):958-63.

PMID:
3129452
36.

The role of T lymphocytes in autoimmune thyroid disease.

Ahmann AJ, Burman KD.

Endocrinol Metab Clin North Am. 1987 Jun;16(2):287-326. Review.

PMID:
3319586

Supplemental Content

Loading ...
Support Center